SCHEMBL4385036

SCHEMBL4385036

CCc1c(OCc2ccccc2)cc(OCc2ccccc2)c(-c2ccc(OC)c(OC)c2)c1CCOCCOC1CCCCO1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
IGF1R P08069 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
ABCB1 P08183 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PDE4A P27815 2/20 0.34
PDE4B Q07343 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384978 0.87 KDM4C (0.35) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL4378293 0.87 KDM4C (0.35) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL4389473 0.84 KDM4C (0.40) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL4389550 0.82 KDM4C (0.40) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL4381851 0.81 ABCB1 (0.45) NPC1RAB9AKDM4EALDH1A1TSHR
SCHEMBL4386208 0.81 KDM4C (0.42) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL4389503 0.74 KDM4C (0.38) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL4381653 0.74 KDM4C (0.35) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL4382823 0.72 KDM4C (0.49) KDM4CNPC1RAB9AKDM4EMEN1
SCHEMBL4384147 0.71 ALDH1A1 (0.34) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P KDM4C 4309/4885NPC1 1090/4885RAB9A 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.